Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future.
peer reviewed ; [en] BACKGROUND: Solid cancer is an independent prognostic factor for poor outcome with COVID-19. As guidelines for patient management in that setting depend on retrospective efforts, we here present the first analyses of a nationwide database of patients with cancer hospitalized with COVID-19 in Belgium, with a focus on changes in anticancer treatment plans at the time of SARS-CoV-2 infection. METHODS: Nineteen Belgian hospitals identified all patients with a history of solid cancer hospitalized with COVID-19 between March 2020 and February 2021. Demographic, cancer-specific a... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journal article |
Erscheinungsdatum: | 2022 |
Verlag/Hrsg.: |
Elsevier B.V.
|
Schlagwörter: | COVID-19 / cancer / prognosis / solid tumours / treatment changes / Humans / Belgium/epidemiology / SARS-CoV-2 / Retrospective Studies / COVID-19 Testing / Medical Oncology / Registries / Lung Neoplasms/drug therapy / Belgium / Lung Neoplasms / Oncology / Cancer Research / Human health sciences / Sciences de la santé humaine / Oncologie |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26585236 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/300417 |